← Back to catalogue

EPORE XO Cup System

FDA 510(k)EUDAMED

Class II (US FDA 510(k))

510(k) K252451Ref 77801030Model MUT12DITINST

by implantcast GmbH

Identity

Trade Name
EPORE® EUDAMED
Device Name
- EUDAMED
Model / Reference
MUT12DITINST EUDAMED
77801030 EUDAMED

Identifiers

Primary DI / UDI-DI
04048844438609 EUDAMED
Basic UDI-DI
4048844MUT12DITINSTH6 EUDAMED
510(k) Number
K252451 FDA 510(k)
FDA Product Code
OQI FDA 510(k)
EMDN Code
L091199 ORTHOPAEDIC PROSTHETICS INSTRUMENTS, REUSABLE - OTHER EUDAMED

Classification

Device Class
Class IIa EUDAMED
Class II FDA 510(k)
Legislation / Framework
21 CFR Part 888.3353 FDA 510(k)
Regulation Number
888.3353 FDA 510(k)
Market of Registration
Germany EUDAMED
Advisory Committee
Orthopedic FDA 510(k)
FDA Decision
SESE Substantially Equivalent FDA 510(k)

Clinical & Handling

Sterile

No

EUDAMED

Implantable

No

EUDAMED

Reusable

No

EUDAMED

Contains Latex

No

EUDAMED

Reprocessed

No

EUDAMED

CMR Substance

Yes

EUDAMED

Human-derived

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Endocrine Disruptor

No

EUDAMED

Administering Medicine

No

EUDAMED

Measuring Function

No

EUDAMED

Incorporates Medicinal Product

No

EUDAMED

The EPORE XO Cup System is a semi-constrained hip implant designed for cemented or porous uncemented fixation, combining metal, ceramic, and polymer components. It is classified as a hip prosthesis and serves as an orthopedic solution for total hip arthroplasty, providing stability and articulation for the femoral head within the acetabular component.

This system is supplied sterile and intended for single-use in orthopedic surgical settings. It is classified under FDA device class II and has received FDA 510(k) clearance and MDR authorization. The system includes various sizes and configurations, as referenced by the listed FEI numbers, and must be handled according to sterile surgical protocols. No MRI safety information is specified in the provided data.

Frequently asked questions

What types of fixation options are available with the EPORE® XO cup system, and how does this affect its use in surgery?

The EPORE® XO cup system is designed for two distinct fixation methods: cemented or porous uncemented. This flexibility allows surgeons to choose based on patient-specific factors like bone quality, age, or clinical needs. Cemented fixation is ideal for patients with weaker bone density, while porous uncemented fixation may be preferred for younger, more active patients or those requiring long-term stability without cement.

How many sizes and configurations are available for the EPORE® XO cup system, and how are they identified?

The system includes a wide range of sizes and configurations, each identified by unique FEI numbers (e.g., 3000215103, 3004748528, etc.). Over 100 distinct FEI numbers are listed, ensuring compatibility with various patient anatomies and surgical requirements. These numbers correspond to specific acetabular cup designs, sizes, and orientations to optimize fit and function during total hip arthroplasty.

Is the EPORE® XO cup system intended for reuse in surgical settings, and what are the handling requirements?

No, the EPORE® XO cup system is explicitly intended for single-use only in sterile surgical settings. As it is supplied sterile, it must be handled according to strict aseptic protocols to maintain sterility until implantation. Reuse is not permitted, as this could compromise patient safety and device integrity.

What materials are used in the construction of the EPORE® XO cup system, and how do they contribute to its function?

The system combines metal, ceramic, and polymer components to create a semi-constrained hip prosthesis. The metal and ceramic components provide durability and wear resistance, while the polymer elements enhance articulation and stability. This combination ensures long-term performance, reduced friction, and improved load distribution for the femoral head within the acetabular cup.

What regulatory pathways has the EPORE® XO cup system undergone, and what does this mean for its use in clinical practice?

The system has received FDA 510(k) clearance under the Traditional 510(k) pathway and MDR authorization, confirming its compliance with U.S. and EU regulatory standards. This means it has been evaluated for safety and effectiveness by regulatory bodies, ensuring it meets established performance criteria for hip prostheses. Clinicians can rely on its regulatory approval when selecting it for total hip arthroplasty procedures.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Authorization Coverage (2 countries)

Regulatory Authorizations

European Union Active

MDR

United States Active

FDA_510K

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
implantcast GmbH

Sources (2)

  • FDA 510(k) K252451 24 fields · synced Oct 6, 2026
  • EUDAMED dc18517c-ddcc-4ff8-b6d0-1a14348560a2 61 fields · synced Sep 17, 2026